A lesser-known issue is that the health risks linked to arsenic exposure in Bangladesh affect people beyond its borders. Bangladesh is the 6th largest country when it comes to sending migrants abroad. In 2020, around 7.4 million Bangladeshis lived overseas, mainly young men, many of whom might have been exposed to arsenic in their youth.
A sizable number of these migrants now live in the European Union (EU). In 2021, there were about 456,516 reported by the International Organisation for Migration (IOM). As migration continues to grow, especially in Mediterranean regions, the health implications are significant.
The EU has updated its cancer screening policy, which aims for better early detection of various cancers. In December 2022, the EU Council recommended new guidelines for screening breast, cervical, and colorectal cancers. For the first time, lung, prostate, and gastric cancers were also included in these recommendations. However, these initiatives don’t fully consider the specific risks faced by Bangladeshi migrants, particularly those with a history of arsenic exposure.
Many doctors in Europe aren’t aware of arsenic-related health issues common in developing countries. As a result, there are no specific cancer screening programs for these migrants. This lack of targeted care can lead to late diagnoses or misdiagnoses. Moreover, migrants often underestimate the risks associated with arsenic exposure, making it hard to involve them in preventive measures.
Currently, the EU’s guidelines don’t offer population-based screening for liver or bladder cancers. They also mostly focus on age and smoking history for lung cancer screenings, ignoring environmental factors like arsenic exposure that could put migrants at greater risk.
To address this gap, EU countries could consider pilot programs tailored to these exposed populations. Such programs could combine risk factors related to arsenic exposure into their screening criteria. This could involve creating a system to identify high-risk individuals, particularly those with chronic exposure or other health risks.
One useful tool could be the Lifetime Average Daily Dose (LADD), which assesses long-term arsenic exposure through drinking water. By integrating LADD metrics into screening guidelines, health authorities could better identify those at risk, ensuring that health measures are both effective and efficient.
In essence, addressing the cancer screening needs of Bangladeshi migrants involves a nuanced understanding of their unique risks. Tailoring screening programs to account for these factors could drastically improve their health outcomes.
Source link
Diseases,Social sciences,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Oncology,Drug Resistance
